Steve Labbe
9Patents
2h-index
10Co-inventors
44Inventor score
Filing activity: Dec 20, 2002 → Jul 7, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7262024B2 | Streptococcus antigens | Chemistry; Metallurgy | 7 | Expired |
| US8945577B2 | Fusion proteins and combination vaccines comprising Haemophilus influenzae Protein E and Pilin A | Emerging Cross-Sectional Technologies | 3 | Active |
| US9296794B2 | Fusion proteins and combination vaccines comprising Haemophilus influenzae Protein E and Pilin A | Emerging Cross-Sectional Technologies | 2 | Active |
| US10730917B2 | Fusion proteins and combination vaccines comprising haemophilus influenzae Protein E and Pilin A | Emerging Cross-Sectional Technologies | 1 | Active |
| US9409957B2 | Fusion proteins and combination vaccines comprising Haemophilus influenzae Protein E and Pilin A | Emerging Cross-Sectional Technologies | 1 | Active |
| US10214569B2 | Fusion proteins and combination vaccines comprising Haemophilus influenzae protein E and pilin A | Emerging Cross-Sectional Technologies | 1 | Active |
| US10023616B2 | Fusion proteins and combination vaccines comprising Haemophilus influenzae Protein E and Pilin A | Emerging Cross-Sectional Technologies | 1 | Active |
| US9314518B2 | Treatment of streptococcal infections | Human Necessities | 0 | Active |
| US11198707B2 | Fusion proteins and combination vaccines comprising Haemophilus influenzae Protein E and Pilin A | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.